Atomo Diagnostics (ASX:AT1) Other Stockholders Equity: A$-0.00 Mil (As of Dec. 2025)


What is Atomo Diagnostics Other Stockholders Equity?

Atomo Diagnostics ASX:AT1 Other Stockholders Equity is A$-0.00 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Atomo Diagnostics's Other Stockholders Equity for the quarter that ended in Dec. 2025 was A$-0.00 Mil.

Atomo Diagnostics's quarterly Other Stockholders Equity increased from Dec. 2024 (A$-0.00 Mil) to Jun. 2025 (A$0.00 Mil) but then declined from Jun. 2025 (A$0.00 Mil) to Dec. 2025 (A$-0.00 Mil).

Atomo Diagnostics's annual Other Stockholders Equity increased from Jun. 2023 (A$-0.00 Mil) to Jun. 2024 (A$0.00 Mil) but then declined from Jun. 2024 (A$0.00 Mil) to Jun. 2025 (A$0.00 Mil).

Atomo Diagnostics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Atomo Diagnostics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atomo Diagnostics Other Stockholders Equity Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Stockholders Equity
Get a 7-Day Free Trial 0.00 -0.00 -0.00 0.00 0.00

Atomo Diagnostics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 -0.00 0.00 -0.00

Atomo Diagnostics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of A$-0.00 Mil mean?
Atomo Diagnostics (ASX:AT1) has a Other Stockholders Equity of A$-0.00 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Atomo Diagnostics and its competitors.
Is Atomo Diagnostics' Other Stockholders Equity too high?
Atomo Diagnostics' current Other Stockholders Equity is A$-0.00 Mil.
How does Atomo Diagnostics' Other Stockholders Equity compare to ABT and SYK?
Atomo Diagnostics' Other Stockholders Equity of A$-0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Atomo Diagnostics and its competitors. Atomo Diagnostics's current Other Stockholders Equity is A$-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atomo Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Atomo Diagnostics (ASX:AT1) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.02 — trading 10% below its estimated fair value. The current Other Stockholders Equity is A$-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Atomo Diagnostics (ASX:AT1), the current Other Stockholders Equity is A$-0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atomo Diagnostics Business Description

Address 3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.